Effect of FPP on Cutaneous Barrier Integrity
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT07725835
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Healthy Volunteers
- Skin Barrier Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Fermented Papaya Preparation (FPP) — DIETARY_SUPPLEMENTImmun'Age Fermented Papaya Preparation
Study Details
This pilot study will test how Fermented Papaya Preparation (FPP) impacts overall TEWL of areas that commonly display diminished barrier function, such as the skin from face, arms, and hands. Areas of diminished barrier function are defined as those not visible to the eye but identified as areas of high transepidermal water loss (TEWL) as measured by a non-invasive pen-like device. A TEWL value of 20 or higher at a location would be considered high TEWL. Participants will attend 5 visits over 20 weeks, with 12-weeks of FPP treatment, and 8-weeks of follow-up.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Apr 30, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Fermented Papaya PreparationFermented Papaya Preparation Supplement
Primary Outcome Measure
Transepidermal Water Loss (TEWL) [ Time Frame: From enrollment to the end of FPP at 12 weeks. ]
Central Contacts
- Savita Khanna, PhD412-624-5500
- Scot King, DPT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| McGowan Institute for Regenerative Medicine | Pittsburgh | Pennsylvania | 15219 | Scot King, DPT Savita Khanna, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
Related Studies
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseasePHASE1/PHASE2 · Recruiting · Bristol-Myers Squibb · Birmingham, Alabama
- Kaempferol Absorption and Pharmacokinetics EvaluationRecruiting · University of Pittsburgh · New York, New York
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and OlderPHASE1/PHASE2 · Recruiting · Sanofi · Gadsden, Alabama
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland